Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited release of its MicroCross Catheter, the latest addition to Roxwood Medical’s expanding product line. The MicroCross Catheter is U.S. Food and Drug Administration (FDA)-cleared and offered in two sizes (Micro14 and Micro18) for use in the coronary and peripheral vasculatures, providing enhanced guidewire support through challenging and tortuous anatomy.

Stroke is the third leading cause of death in the Western industrialized world, and according to the Centers for Disease Control (CDC), accounts for one of every 19 deaths in the United States each year. Over 80 percent of strokes are ischemic in nature, caused by clots and other obstructions in vessels that supply blood to the brain, and cardiac embolism accounts for approximately one-third of all cases of ischemic stroke. Echocardiography in general and transesophageal echocardiography in particular are essential for evaluation, diagnosis and management of stroke and systemic embolism. A new document, Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism, will appear in the January 2016 issue of the Journal of the American Society of Echocardiography (JASE) and provides the first set of guidelines from the American Society of Echocardiography (ASE) specific to this topic.

January 7, 2016 — Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or shortly after giving birth share certain genetic changes.

Corindus Vascular Robotics Inc. announced the launch of a CorPath robotic-assisted coronary intervention program at Massachusetts General Hospital (MGH) and the installation of its first CorPath System.


Clinical decision support (CDS) software has been discussed for years as a way to help clinicians follow best practice guidelines and help eliminate unnecessary tests or procedures. However, implementing these systems has been slow, partly due to their cost and complexity and pushback from physicians. But, a new chapter is about to open for CDS as healthcare reform will soon require implementation of these systems.

A new study determined that the Watchman left atrial appendage closure device is more cost-effective than warfarin and non-warfarin oral anticoagulants (NOACs) for stroke reductions in non-valvular atrial fibrillation patients.

The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries of Mallinckrodt plc will acquire The Medicines Company’s global portfolio of hemostasis products.

A new study from the Healthcare Information and Management Systems Society (HIMSS) offers insight from nearly 200 healthcare executives (C-Suite, administrators, directors and vice presidents) on their population health initiatives, and their current and future approach to population health IT solutions and consultants.

Johns Hopkins has demonstrated in animals that applying a pacemaker’s mild electrical shocks to push the heart in and out of normal synchronized contraction for part of each day may be an effective way to slow down the progression of heart failure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now